About
How does CLUSTREL Technology work?
Before reaching the clinic, CLUSTREL is undergoing rigorous testing in advanced in-vitro and in-vivo pre-clinical models. Through this exhaustive evaluation, CLUSTREL will demonstrate:
Pharmacokinetics
Tracking exactly how the body absorbs, distributes, and metabolizes the formulation.
Efficacy
Measuring the direct, powerful therapeutic impact on acute seizure activity.
Permeability
Proving optimal barrier crossing for targeted, rapid drug delivery.
Pharmacodynamics
Evaluating the precise biochemical and physiological effects over time.
Biocompatibility
Ensuring seamless, safe, and non-invasive integration with living tissue.
Designed with Patients & Clinicians
CLUSTREL collaborates directly with the entire epilepsy ecosystem, including patient end-users, neurologists, oral medicine specialists, regulators, pharmaceutical companies, and MedTech leaders.
Built for Regulatory Compliance
CLUSTREL is developed in strict alignment with international medical device and pharmaceutical standards. By embedding quality and compliance into our foundational R&D, CLUSTREL paves a clear pathway toward future CE and FDA approvals.
Human-Centered Design
Through empathetic, user-first engineering, CLUSTREL delivers a solution that is:
Comfortable & Intuitive
Easy to wear and completely stress-free to use.
Accessible in Crises
Engineered to function flawlessly in high-stress emergency scenarios.
Empowering
Built to restore patient independence while giving caregivers ultimate confidence.
Preparing for Market Impact
Parallel to our technical development, CLUSTREL builds market readiness by establishing:
01
Strategic Industrial Collaborations to accelerate our development timeline.
02
Pharmaceutical Partnerships to co-deliver leading anti-epileptic drug portfolios.
03
A Validated Business Model designed for sustainable, global market entry.